Tirzepatide
5 mg · 99.89% purity · report date 06/08/2026
Laboratory reports for matching launch-product specifications. Public copies are prepared to protect upstream sourcing. Submitter names, supplier-facing identifiers, upstream lot references, purchase information, and direct verification/search tokens are omitted from the customer-facing copy. Laboratory identity, test dates, methods, and analytical results are preserved.
5 mg · 99.89% purity · report date 06/08/2026
5 mg · 99.78% purity · report date 06/08/2026
50 mg · 99.65% purity · report date 08/12/2026
5 mg + 5 mg · 99.89% purity · report date 08/04/2026
5 mg · 99.93% purity · report date 07/18/2026
These reports document different tested strengths from the current launch SKUs. They are provided as reference documentation only and are not labeled as batch-specific COAs for the products currently offered.
Reference: 10 mg · 99.81% purity · current PEPPAVITA SKU: 5 mg
Reference: 10 mg + 10 mg · 99.47% purity · current PEPPAVITA SKU: 5 mg + 5 mg
Privacy audit standard: Customer-facing analytical files must not expose supplier names, supplier contact details, supplier codes, upstream order references, submitter/customer names, or vendor-specific lot identifiers. Those records stay in PEPPAVITA's private traceability file.
Public pages use PEPPAVITA-facing product identifiers. Supplier names, supplier lot numbers, purchase records, and upstream sourcing details are maintained internally for traceability rather than published as customer-facing information.
Each laboratory report applies only to the sample submitted for analysis and should not be interpreted as proof that every vial in inventory was individually tested.